Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

患者の権利の認識:不完全な進展

S Kaur1, A Herxheimer

  • 1Regional Office for Asia and the Pacific, International Organisation of Consumers' Unions, Penang, Malaysia.

Lancet (London, England)
|January 15, 1994
PubMed
まとめ

No abstract available in PubMed .

キーワード:
プロフェッショナル 患者との関係 患者との関係

関連する実験動画

関連する概念動画

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Teaching practical prescribing and therapeutics.

Medical teacher·2014
Same author

Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France.

Journal of clinical pharmacy and therapeutics·2013
Same author

Side effects: freedom of information and the communication of doubt.

The International journal of risk & safety in medicine·2013
Same author

The Cochrane CollaborationMaking the results of controlled trials properly accessible.

The International journal of risk & safety in medicine·2013
Same author

What people close to death say about euthanasia and assisted suicide: a qualitative study.

Journal of medical ethics·2006
Same author

[DIPEx (Database of Individual Patients Experience of illness): a multimedia proposal to share experiences and information about illnesses between patients and health professionals].

Atencion primaria·2003
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る